NARROW SPECTRUM KINASE INHIBITORS (NSKI) TARGET KINASES INVOLVED IN BOTH INNATE AND ADAPTIVE IMMUNE RESPONSES LEADING TO POTENT AND HIGHLY EFFICACIOUS EFFECTS IN EXPERIMENTAL MODELS OF INFLAMMATORY BOWEL DISEASE

Sameer Sirohi  1     Yemisi Solanke  1     Matthew Butler  1     Martyn Foster  1     Matthew Fyfe  1     Paolo Biancheri  2     Thomas Thornton MacDonald     Steve Webber     Claire Walshe    
1 Topivert Pharma Ltd, London, United Kingdom
2 Centre For Immunology And Infectious Disease, Blizard Institute, Barts And The London School Of Medicine And D

Conference
UEG Week 2014

Citation
United European Gastroenterology Journal; 2014: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing